Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma

Martha Arellano,S. Lonial,Amelia Langston,Christopher R. Flowers,T. Heffner,Donald Hutcherson,Winton Ef,Edmund K. Waller

Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma

2005

Martha Arellano
S. Lonial
Amelia Langston
Christopher R. Flowers
T. Heffner
Donald Hutcherson
Winton Ef
Edmund K. Waller

6691 Background:High dose chemotherapy and autologous transplant remains the goal for patients with chemo-responsive relapsed lymphoma. Microtubule agents (Paclitaxel and Vinorelbine) may synchroni...

Keywords:

Physical therapy
Etoposide
Lymphoma
Cisplatin
Vinorelbine
Paclitaxel
Cytarabine
Cancer research
Medicine
dose escalation
Internal medicine
fixed dose
Pathology
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations